A Japanese study suggests that lubiprostone, a common constipation drug, may help slow kidney decline in people with chronic ...

A common constipation drug, lubiprostone, shows remarkable potential in slowing kidney function decline for chronic kidney ...

When a phase two clinical trial from Japan suggested that a common constipation medicine might slow the progression of ...

You might've heard too many eggs make you constipated. Influencers on Instagram claim it too. The United Kingdom has slang for it—being "egg bound." Eggs were once blamed for raising blood cholesterol ...

Chronic kidney disease (CKD) affects people across the globe and often progresses to the point where patients rely on routine dialysis to survive. Although the condition is widespread and ...

Researchers have discovered that a common constipation drug can slow kidney decline in CKD patients. This is a new frontier ...

Professor Takaaki Abe and his team discovered that a medicine called lubiprostone, which is normally used to treat ...

Two-year epcoritamab monotherapy data demonstrate high complete response and encouraging survival rates in patients with Richter transformation (RT), highlighting its potential as a treatment option ...

Working with Varian, a key player in EBRT, Telix will explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment. The ...

Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

New investigational data from Phase 1/2 study of enzomenib (DSP-5336) in patients with relapsed/refractory acute myeloid leukemia (AML) show clinical ...